17218-Ovarian Cancer-NA-448

Ovarian Cancer

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Address

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.